Terms: = Leukemia AND MLF1, P58340, 4291, ENSG00000178053
47 results:
1. Epigenetic deregulation of mlf1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling.
Tang Z; Yang Y; Chen W; Liang T
Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37486965
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression].
Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a cryptic submicroscopic deletion using a combination of fluorescence in situ hybridization and array comparative genomic hybridization in a t(3;5)(q25;q35)-positive acute myeloid leukemia patient: A case report and review of the literature.
Gao M; Li S; Wang L; Nie S; Pang H; Lu X; Wang X; Wang M; Guo S; Ma Y; Meng F
Medicine (Baltimore); 2020 Oct; 99(43):e22789. PubMed ID: 33120794
[TBL] [Abstract] [Full Text] [Related]
4. CRL4
Huang D; Liu C; Sun X; Sun X; Qu Y; Tang Y; Li G; Tong T
Biochem Biophys Res Commun; 2020 Aug; 529(2):127-132. PubMed ID: 32703400
[TBL] [Abstract] [Full Text] [Related]
5. CIMT does not identify early vascular changes in childhood acute lymphoblastic leukemia survivors.
Ociepa T; Posio W; Sawicki M; Urasiński T
Adv Clin Exp Med; 2020 Feb; 29(2):243-249. PubMed ID: 32073764
[TBL] [Abstract] [Full Text] [Related]
6. NPM and NPM-mlf1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
[TBL] [Abstract] [Full Text] [Related]
8. Common variants upstream of mlf1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.
McDaniel LD; Conkrite KL; Chang X; Capasso M; Vaksman Z; Oldridge DA; Zachariou A; Horn M; Diamond M; Hou C; Iolascon A; Hakonarson H; Rahman N; Devoto M; Diskin SJ
PLoS Genet; 2017 May; 13(5):e1006787. PubMed ID: 28545128
[TBL] [Abstract] [Full Text] [Related]
9. mlf1 is a proapoptotic antagonist of HOP complex-mediated survival.
Sun Y; Chao JR; Xu W; Pourpak A; Boyd K; Moshiach S; Qi GY; Fu A; Shao HR; Pounds S; Morris SW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):719-727. PubMed ID: 28137643
[TBL] [Abstract] [Full Text] [Related]
10. Myeloid leukemia factor-1 is a novel modulator of neonatal rat cardiomyocyte proliferation.
Rangrez AY; Pott J; Kluge A; Frauen R; Stiebeling K; Hoppe P; Sossalla S; Frey N; Frank D
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):634-644. PubMed ID: 28087342
[TBL] [Abstract] [Full Text] [Related]
11. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract] [Full Text] [Related]
12. Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.
Sun Y; Fu A; Xu W; Chao JR; Moshiach S; Morris SW
J Physiol Biochem; 2015 Dec; 71(4):807-21. PubMed ID: 26563351
[TBL] [Abstract] [Full Text] [Related]
13. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
[TBL] [Abstract] [Full Text] [Related]
14. mlf1 interacting protein: a potential gene therapy target for human prostate cancer?
Zhang L; Ji G; Shao Y; Qiao S; Jing Y; Qin R; Sun H; Shao C
Med Oncol; 2015 Feb; 32(2):454. PubMed ID: 25572810
[TBL] [Abstract] [Full Text] [Related]
15. Development of an NPM1/mlf1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia.
Aypar U; Knudson RA; Pearce KE; Wiktor AE; Ketterling RP
J Mol Diagn; 2014 Sep; 16(5):527-532. PubMed ID: 25027285
[TBL] [Abstract] [Full Text] [Related]
16. A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.
Woolthuis CM; Mulder AB; Verkaik-Schakel RN; Rosati S; Diepstra A; van den Berg E; Schuringa JJ; Vellenga E; Kluin PM; Huls G
Haematologica; 2013 Oct; 98(10):1532-8. PubMed ID: 23716555
[TBL] [Abstract] [Full Text] [Related]
17. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract] [Full Text] [Related]
18. Subcellular localization of full-length human myeloid leukemia factor 1 (mlf1) is independent of 14-3-3 proteins.
Molzan M; Ottmann C
Cell Mol Biol Lett; 2013 Mar; 18(1):137-48. PubMed ID: 23271436
[TBL] [Abstract] [Full Text] [Related]
19. Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.
Gobert V; Haenlin M; Waltzer L
Transcription; 2012; 3(5):250-4. PubMed ID: 22885977
[TBL] [Abstract] [Full Text] [Related]
20. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
[TBL] [Abstract] [Full Text] [Related]
[Next]
